Keywords: 6-MP, 6-mercaptupurine; CMM, cutaneous malignant melanoma; ENAMS, eruptive nevi associated with medications; ENM, eruptive melanocytic nevi; L-DOPA, levodopa; PD, Parkinson disease; Parkinson disease; carbidopa-levodopa; eruptive melanocytic nevi; eruptive nevi associated with medications; melanoma.